{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:48:05Z","timestamp":1747154885422,"version":"3.40.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine and Surgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.amsu.2020.08.011","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T06:41:04Z","timestamp":1597214464000},"page":"307-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Challenging lymphoid malignancy of primary central nervous system lymphoma: A case report"],"prefix":"10.1097","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-9261","authenticated-orcid":false,"given":"Ganesh","family":"Kasinathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahlam Naila","family":"Kori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurhidayah","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.amsu.2020.08.011_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ajh.23551","article-title":"The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle\u2010aged men and differs from time trends in systemic diffuse large B\u2010cell non\u2010Hodgkin's lymphoma","volume":"88","author":"O'Neill","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.amsu.2020.08.011_bib2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/bjc.2011.357","article-title":"Age, gender, and racial differences in incidence and survival in primary CNS lymphoma","volume":"105","author":"Villano","year":"2011","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.amsu.2020.08.011_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3816\/CLM.2009.n.070","article-title":"Management of immunocompetent patients with primary central nervous system lymphoma","volume":"9","author":"Chimienti","year":"2009","journal-title":"Clin. Lymphoma Myeloma"},{"key":"10.1016\/j.amsu.2020.08.011_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring systems of primary CNS lymphoma: the international extranodal lymphoma study group experience","volume":"21","author":"Ferreri","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.amsu.2020.08.011_bib5","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/WNL.58.10.1513","article-title":"A multicenter study of treatment of primary CNS lymphoma","volume":"58","author":"Ferreri","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.amsu.2020.08.011_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille","year":"2000","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.amsu.2020.08.011_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1182\/blood-2011-03-321349","article-title":"How I treat primary CNS lymphoma","volume":"118","author":"Ferreri","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.amsu.2020.08.011_bib8","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/leu.2017.170","article-title":"High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma\u2014a prospective multicentre trial by the German Cooperative PCNSL study group","volume":"31","author":"Kasenda","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.amsu.2020.08.011_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","article-title":"Non-Hodgkin lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiotherapy oncology group (RTOG)","volume":"23","author":"Nelson","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.amsu.2020.08.011_bib10","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","article-title":"Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology","volume":"16","author":"Hoang-Xuan","year":"2015","journal-title":"Lancet Oncol."},{"issue":"24","key":"10.1016\/j.amsu.2020.08.011_bib11","doi-asserted-by":"crossref","first-page":"p4643","DOI":"10.1200\/JCO.2002.11.013","article-title":"Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: radiation Therapy Oncology Group Study 93-10","volume":"20","author":"DeAngelis","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.amsu.2020.08.011_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma. A phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.amsu.2020.08.011_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tranon.2018.11.011","article-title":"Primary central nervous system lymphoma: molecular pathogenesis and advances in treatment","volume":"12","author":"Cai","year":"2019","journal-title":"Transl. Oncol."},{"issue":"25","key":"10.1016\/j.amsu.2020.08.011_bib14","first-page":"419","article-title":"The diagnosis and treatment of Primary CNS Lymphoma","volume":"115","author":"Von Baumgarten","year":"2018","journal-title":"Dtsch. Arzteblatt Int."},{"key":"10.1016\/j.amsu.2020.08.011_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12032-014-0351-7","article-title":"Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma","volume":"32","author":"Zhao","year":"2015","journal-title":"Med. Oncol."}],"container-title":["Annals of Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120302582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120302582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:09:15Z","timestamp":1677082155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2049080120302582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":15,"alternative-id":["S2049080120302582"],"URL":"https:\/\/doi.org\/10.1016\/j.amsu.2020.08.011","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"print","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenging lymphoid malignancy of primary central nervous system lymphoma: A case report","name":"articletitle","label":"Article Title"},{"value":"Annals of Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amsu.2020.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}